New menin/MLL interaction inhibitors patented by University of Michigan, Agios Pharmaceuticals April 27, 2020
Oryzon to initiate phase II ESCAPE study of vafidemstat in severely ill COVID-19 patients in Spain April 27, 2020
RSS